Characterization of Mechanisms Involved in Transrepression of NF-κB by Activated Glucocorticoid Receptors

Cited by (831)

Items 801–831 of 831

1. Corticosteroid Biology in Critical Illness: Modulatory Mechanisms and Clinical Implications
   M. Williams, David Krishna Menon · 2009 · Springer eBooks
2. Glucocorticoids
   C.E. Sekeris · 2002 · Wiley eBooks
3. Multi-site therapeutic modalities for inflammatory bowel diseases — mechanisms of action
   Gerhard Rogler · 2003 · Springer eBooks
4. Androgens, Anabolic Steroids, and Glucocorticoids
   M D., Shehzad Sultan Basaria, Lindsey Harle, Adrian Sandra Dobs · 2005 · CRC Press eBooks
5. 烫伤对小鼠腹腔巨噬细胞LPS/Toll信号通路的影响——c-fos基因表达、AP-1和NF-κB的DNA结合活性及IL-12 p40基因表达的抑制
   2002 · Science in China Series C-Life Sciences (in Chinese)
6. References
   2011 · Elsevier eBooks
7. The role of the Glucocorticoid Receptor in intestinal inflammation and tumorigenesis in a murine model of colitis and colitis-associated colorectal cancer
   Chiara Muzzi · 2022
8. Acute Effects of Systemic Glucocorticoids on the Vocal Folds in a Pre-Clinical Model
   Gary J. Gartling, Ryosuke Nakamura, Lea Sayce, Emily E. Kimball, Azure Wilson, Steven J. Schneeberger, Zachary Zimmerman, Michael J. Garabedian, Ryan C. Branski, Bernard Rousseau · 2023 · Annals of Otology Rhinology & Laryngology
9. Systemic glucocorticoid therapy for SLE
   Champa Nataraja, Eric Francis Morand, Anselm Mak · 2024 · Elsevier eBooks
10. Glucocorticoid Receptor Signaling in Myeloid Cells Orchestrates Inflammation Resolution and Muscle Repair
    Sirine Souali-Crespo, Joe G. Rizk, Emilia Calvano, Rajesh Sahu, Emina Colovic, Imane Chabba, Valentine Gilbart, Erwan Grandgirard, Bastien Morlet, Qing-Shuang Cai et al. · 2026 · bioRxiv
11. Multi-site therapeutic modalities for inflammatory bowel diseases — mechanisms of action
    Gerhard Rogler · 2007 · Springer eBooks
12. Rol de la inflamación sistémica en la patología generada por tumores murinos
    Juan Bruzzo · 2014
13. Genetic analysis of thymocyte apoptosis
    David J. Askew · 1999 · UA Campus Repository (The University of Arizona)
14. Glucocorticoid regulation of GM-CSF in bronchial epithelial cells
    Karissa Adkins · 1998 · UA Campus Repository (The University of Arizona)
15. Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1
    Laudine Communal · 2011 · theses.fr (ABES)
16. Caractérisation immunologique et protéomique des cellules dendritiques tolérogènes humaines. Application à la recherche de biomarqueurs de l’immunothérapie spécifique allergénique
    Aline Zimmer · 2011 · theses.fr (ABES)
17. Implication de l'activité constitutive des récepteurs 5-HT4 dans la régulation de la conduite alimentaire : vers une solution thérapeutique
    Laetitia Laurent · 2011 · theses.fr (ABES)
18. Specific activation of the alternative cardiac promoter of Cacna1c by the mineralocorticoid receptor
    Thássio Mesquita · 2017 · theses.fr (ABES)
19. Rôle du récepteur adipocytaire des glucocorticoïdes dans l’expansion et la vascularisation du tissu adipeux
    Anna Vali · 2022 · theses.fr (ABES)
20. Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling
    C F Wang, Lingling Liu, J Y Zhang, Shanliang Sun, Xinyu Lv, Zihao Liu, Lianxin Zhou, Ziang Zhu, Haiwen Ni, Chunyan Gu et al. · 2026 · Journal for ImmunoTherapy of Cancer
21. Chronic Social Stress and Immune Dysregulation: Integrating Neuroendocrine Signaling, Microbiota, and Tissue-Specific Responses
    William P. Lafuse, Murugesan V. S. Rajaram · 2026 · Cells
22. Effect of glucocorticoid production by the enteric nervous system on neuronal connectivity is blocked during inflammation in a GR-dependent pathway
    Justine Blin, Valentine S. Moullé, Zoé Garel, Ulysse Bertholon, Thibauld Oullier, Tony Durand, Catherine Le Berre‐Scoul, Damien Masson, Kalyane Bach‐Ngohou, Michel Neunlist · 2026 · iScience
23. Glucocorticoids in breast cancer: physiologic mechanisms and relationship to risk, survival, and treatment response
    Robert Treat Chatterton, Peter H. Gann · 2026 · Frontiers in Endocrinology
24. Corticosteroids in septic shock: mechanisms, heterogeneous treatment effects, and trajectory-guided precision pharmacotherapy
    Zifei Jia, Xuanyu Zhao, Xiangtian Liu, 李小丽 · 2026 · Frontiers in Pharmacology
25. Decanoic acid additively suppresses IL-1β and enables pharmacologic dexamethasone dose-sparing in LPS/ATP-stimulated THP-1 macrophages
    Melissa A Hausburg, Kaysie L. Banton, Christopher D. Cassidy, Robert M. Madayag, Carlos H. Palacio, Jason S. Williams, Gregory W. Thomas, Raphael Bar-Or, David Bar‐Or · 2026 · PLoS ONE
26. Characterisation of 11beta hydroxysteroid dehydrogenase 1 in ocular and orbital tissues
    Claire Onyimba · 2010 · UPT. Syiah Kuala University Library (Syiah Kuala University)
27. Understanding the proliferative and self-renewal potential of different leukaemic stem cell populations
    Elda Surhaida Latif · 2013
28. Molekulare Mechanismen der Glukokortikoidtherapie
    Thorsten Trapp, Florian Holsboer · 1999 · Springer eBooks
29. NF-кB in the Vascular System
    Rainer de Martin · 2003 · Springer eBooks
30. Untitled work
    Lawrence · 1998 · 10.1002/1529-0131(199805)41:5
31. Oligodendrocytes as glucocorticoids target cells: functional analysis of the glycerol phosphate dehydrogenase gene
    Cheng, Janet D., de Vellis, Jean · 2000 · Journal of Neuroscience Research